A one year postdoctoral position is available for comprehensive bioinformatics analysis of stem-cell derived extracellular vesicles (EVs). The associated research project is being carried out as part of a Mitacs Accelerate grant with an industry partner in the field of EV cosmeceuticals under the supervision of Dr. Stanislav Sokolenko (ssokolen@dal.ca).
The successful candidate will work on developing EV characterization methodology using flow cytometry, proteomics, and RNA sequencing. They will be expected to perform basic lab experiments such as protein and RNA quantification as well as flow cytometry labelling and fixation. The successful candidate will also need to analyze proteomics and RNA sequencing data to characterize EV cargo.
Qualifications/Requirements of Position
The successful candidate is expected to have a completed a PhD project that falls within the broad area of computational biology/bioinformatics, which includes but is not limited to Chemical/Biological Engineering, Computer Science, or Biology. The potential candidate should have an established publication record, strong background in bioinformatics, and first-hand experience with at least one of the following methodologies: flow cytometry, proteomics, and RNA sequencing. A strong programming background is preferred but not required.
Salary Range/Pay Rate
$40,000 to $45,000
Additional Information
Dalhousie University is committed to fostering a collegial culture grounded in diversity and inclusiveness. The university encourages applications from Indigenous persons (especially Mi’kmaq), persons with a disability, racialized persons, including persons of Black/African descent (especially African Nova Scotians), women, persons of a minority sexual orientation and/or gender identity, and all candidates who would contribute to the diversity of our community. For more information, please visit www.dal.ca/hiringfordiversity
Dalhousie’s vaccine mandate has been suspended at this time, and employees no longer need to provide proof of full vaccination. However, health and safety risks to our community will continue to be monitored and a vaccine mandate may be reinstated if necessary.
